Outlook Therapeutics (OTLK) Misses Q3 EPS by 44c
Tweet
Share
E-mailGet Alerts OTLK Hot Sheet
Join SI Premium – FREE
Outlook Therapeutics (NASDAQ: OTLK) reported Q3 EPS of ($0.44). Revenue for the quarter came in at $1.51 million.
For earnings history and earnings-related data on Outlook Therapeutics (OTLK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Walmart will be lowering prices
- Rivian Automotive (RIVN) files for 75M share offering
- Walmart and Sam's Club cut prices on summer groceries and essentials
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
